DIMENSION THERAPEUTICS
Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. Their team comprises biotech industry veterans and thought leaders in gene therapy and rare diseases. The company is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-class product engine for adeno-associated virus (AAV) therapeutics. In conjunction with its launch, ... Dimension has entered into an exclusive license and collaboration with REGENX Biosciences. REGENX holds exclusive rights to a portfolio of over 100 patents and patent applications pertaining to its NAV vector technology and related applications. Through its license and collaboration with REGENX, Dimension has acquired preferred access to NAV vector technology and rights within REGENX product programs in multiple rare disease indications. Dimension has completed a Series A financing led by Fidelity Biosciences.
DIMENSION THERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
617-401-0011
Email Addresses:
[email protected]
Total Funding:
124.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving IPv6 Cloudflare Google Cloud Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Similar Organizations
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Series B - Dimension Therapeutics
Jennison Associates
Jennison Associates investment in Series B - Dimension Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Dimension Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Dimension Therapeutics
Partner Fund Management
Partner Fund Management investment in Series B - Dimension Therapeutics
Tourbillon Global Ventures
Tourbillon Global Ventures investment in Series B - Dimension Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Dimension Therapeutics
OrbiMed
OrbiMed investment in Series B - Dimension Therapeutics
Fidelity Biosciences
Fidelity Biosciences investment in Series A - Dimension Therapeutics
OrbiMed
OrbiMed investment in Series A - Dimension Therapeutics
More informations about "Dimension Therapeutics"
Ultragenyx Completes Tender Offer and Acquisition of Dimension …
Nov 7, 2017 As a result of the completion of the merger, all remaining eligible Dimension shares were canceled and converted into the right to receive $6.00 per share in cash, without interest …See details»
Dimension Therapeutics - Crunchbase Company Profile & Funding
Dimension Therapeutics closed its last funding round on Apr 21, 2015 from a Series B round. Who are Dimension Therapeutics 's competitors? Alternatives and possible competitors to …See details»
Ultragenyx to Acquire Dimension Therapeutics - GlobeNewswire
Oct 3, 2017 Dimension Therapeutics, Inc. (NASDAQ:DMTX) is a leader in discovering and developing new therapeutic products for people living with devastating rare and metabolic …See details»
Dimension Therapeutics - PitchBook
Dimension Therapeutics General Information Description. Developer of gene therapies for rare diseases. The company develops novel treatment and focus …See details»
Dimension Therapeutics acquired by Ultragenyx Pharmaceutical
Dimension Therapeutics Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases. Acquiring Organization: Ultragenyx Pharmaceutical Ultragenyx …See details»
Dimension Therapeutics to be Acquired by Ultragenyx for $151 …
Oct 5, 2017 Goodwin’s Life Sciences team advised Dimension Therapeutics on its definitive agreement to be acquired by Ultragenyx Pharmaceutical, a biopharmaceutical company …See details»
Dimension Therapeutics, Inc. - Drug pipelines, Patents, …
Explore Dimension Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 37 news, and 3 literature, Drug:DTX-601, DTX-501. ... The statistics for drugs in the Pipeline is the current organization …See details»
Dimension Therapeutics (USA) Funding: $124.5M
Apr 2, 2025 Dimension Therapeutics is developing novel, liver-directed gene therapy treatments for severe, rare genetic disorders. Dimension’s lead programs address significant medical needs for new therapies and include a wholly …See details»
Organization | Dimension Therapeutics - Purdue University
Organization Overview. First Clinical Trial. 2015 NCT02618915. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Dimension Therapeutics, Inc. Active Ingredients. …See details»
Dimension Therapeutics - 2025 Company Profile - Tracxn
Apr 15, 2025 Dimension Therapeutics is an acquired company based in Cambridge (United States), founded in 2013 by Kenneth Mills. It operates as a Provider of gene therapy for rare …See details»
Dimension Therapeutics Inc. - InvestSnips: Your Sector Investment …
Mar 3, 2025 Company Name: Dimension Therapeutics Inc. Dimension Therapeutics Inc. develops therapeutics for rare diseases associated with the liver. The company has several …See details»
Dimension Therapeutics - VentureRadar
Dimension Therapeutics is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in haemophilia, and …See details»
Dimension Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Dimension Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Dimension Therapeutics, Inc. - Drug pipelines, Patents, Clinical …
Explore Dimension Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 16 news, and 1 literature, Disease Domain:Endocrinology and Metabolic …See details»
Dimension Therapeutics - Orphanet
Dimension Therapeutics. Dimension Therapeutics. 840 Memorial Drive - 4th Floor. CAMBRIDGE MA 02139 . UNITED STATES. Contact email: [email protected]. Institution's website …See details»
Dimension Therapeutics - Funding, Financials, Valuation & Investors
Dimension Therapeutics is registered under the ticker NASDAQ:DMTX . Their stock opened with $13.00 in its Oct 22, 2015 IPO. Stock Symbol NASDAQ:DMTX ; IPO Share Price $13.00; IPO …See details»
Dimension Therapeutics - Overview, News & Similar companies
Who is Dimension Therapeutics. Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with ra re and …See details»
Bruised Ultragenyx attempts swoop for in-demand Dimension
Sep 18, 2017 It looked like a done deal: Last month, Regenxbio penned a pact to acquire Dimension Therapeutics for the modest sum of $86 million as it looked to add two early-stage …See details»
Dimension Therapeutics - Contacts, Employees, Board Members, …
Organization. Dimension Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Employee Profiles 3. Number of Board Member and Advisor …See details»
Dimension Therapeutics Company Information - Funding, …
Get information on funding, investors, industries, and more for Dimension Therapeutics. See Dimension Therapeutics company profile and funding data. Mentioned on: FEATURED IN. …See details»